Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gutmann, D. H.
Right arrow Articles by Haipek, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutmann, D. H.
Right arrow Articles by Haipek, C. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 14 1519-1529
© 2001 Oxford University Press

Functional analysis of neurofibromatosis 2 (NF2) missense mutations

David H. Gutmann+, Angela C. Hirbe and Carrie A. Haipek

Department of Neurology, Washington University School of Medicine, Box 8111, 660 South Euclid Avenue, St Louis, MO 63110, USA

Neurofibromatosis 2 (NF2) is a tumor predisposition syndrome in which affected individuals develop nervous system tumors at an increased frequency. The most common tumor in individuals with NF2 is the schwannoma, which is composed of neoplastic Schwann cells lacking NF2 gene expression. Moreover, inactivation of the NF2 gene is observed in nearly all sporadic schwannomas, suggesting that the NF2 gene is a critical growth regulator for Schwann cells. In an effort to gain insights into the function of the NF2 gene product, merlin or schwannomin, we performed a detailed functional analysis of eight naturally occurring non-conservative missense mutations in the NF2 gene. Using a regulatable expression system in rat schwannoma cells, we analyzed proliferation, actin cytoskeleton-mediated events and merlin folding. In this report, we demonstrate that mutations clustered in the predicted {alpha}-helical region did not impair the function of merlin whereas those in either the N- or C-terminus of the protein rendered merlin inactive as a negative growth regulator. These results suggest that the key functional domains of merlin lie within the highly conserved FERM domain and the unique C-terminus of the protein.

+ To whom correspondence should be addressed. Tel: +1 314 362 7149; Fax: +1 314 362 2388; Email: gutmannd@neuro.wustl.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Med. Genet.Home page
M E Baser, L Kuramoto, R Woods, H Joe, J M Friedman, A J Wallace, R T Ramsden, S Olschwang, E Bijlsma, M Kalamarides, et al.
The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2
J. Med. Genet., July 1, 2005; 42(7): 540 - 546.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C.-X. Sun, C. Haipek, D. R. Scoles, S. M. Pulst, M. Giovannini, M. Komada, and D. H. Gutmann
Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate
Hum. Mol. Genet., December 1, 2002; 11(25): 3167 - 3178.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Shimizu, A. Seto, N. Maita, K. Hamada, S. Tsukita, S. Tsukita, and T. Hakoshima
Structural Basis for Neurofibromatosis Type 2. CRYSTAL STRUCTURE OF THE MERLIN FERM DOMAIN
J. Biol. Chem., March 15, 2002; 277(12): 10332 - 10336.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A.-M. Bashour, J.-J. Meng, W. Ip, M. MacCollin, and N. Ratner
The Neurofibromatosis Type 2 Gene Product, merlin, Reverses the F-Actin Cytoskeletal Defects in Primary Human Schwannoma Cells
Mol. Cell. Biol., February 15, 2002; 22(4): 1150 - 1157.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
C.-X. Sun, V. A. Robb, and D. H. Gutmann
Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation
J. Cell Sci., January 11, 2002; 115(21): 3991 - 4000.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.